There were 1,584 press releases posted in the last 24 hours and 450,085 in the last 365 days.

MicroRNA (miRNA) Market To Reach USD 415.1 Million By 2026 | Reports And Data

Investments in the development of techniques & tools to overcome existing challenges in clinical translation of microRNA applications, strategic developments such as partnerships and mergers and acquisitions, favourable research funding scenario, and development of advanced genomic analysis techniques for quality control during miRNA manufacturing are key factors contributing to high CAGR of MicroRNA (miRNA) Market during forecast period.

Market Size – USD 171.4 Million in 2018, Market Growth - CAGR of 11.6%, Market Trends – Product launches and research for MicroRNA (miRNA) market.

NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Silicon Nitride market was valued at USD 88.1 million in 2018 and is expected to reach USD 157.5 million by year 2026, at a CAGR of 7.5 percent.

Silicon Nitride (Si3N4), a non-oxide ceramic has an excellent combination of material properties. They are as light weighted as silicon carbide (SiC), but their microstructure gives them excellent thermal shock resistance and their high fracture toughness makes them resistant to impacts and shocks. Si3N4 Ceramics is used for ball bearings, ceramic forming tools and automotive components and even due to its high temperature resistance; it is used for welding process.

Request free sample of this research report at:

Government investment and advancements in technology are anticipated to further drive growth. High prevalence of diseases is expected to encourage pharmaceutical and biotech companies to engage in R&D in different disease classes.  Expansion, authorisation, and launch of products for use in hospitals and clinics face various challenges due to reproducibility and consistency issues.

Further key findings from the report suggest

  • miRNA Market is fastest growing at a CAGR of 6% in Asia Pacific followed by Europe respectively. High progress in genomics and upcoming M&A deals are the key factors to propel the market growth during the forecast period across these
  • qRT-PCR segment type has the largest market share of 37.3%
  • Microarray Analysis Tools are also one of the key technologies employed in the functional studies of these molecules which drive the market for miRNA with a CAGR of 11.2%
  • Europe accounts for the second largest market share of the global miRNA market at 29.2% due to huge approval of fund through European Union
  • The Pharmaceutical and Biotech Companies end use segment is expected to register largest CAGR of 11.8% during 2019-2026 due to rapid usage of research tools
  • Key participants include Agilent Technologies, Exigon, Merck KGA, Illumina, Inc., NanoString Technologies, Inc., and Thermo Fischer Scientific Inc
  • United States, France, Germany, United Kingdom, China, Israel, and Korea are the significant players interested in evaluating the potential of miRNA in the global market
  • Advancements in analytical techniques that enable accurate detection & quantification of MicroRNAs are factors propelling the market growth
  • Immense Cost acquainted With MicroRNA Kits and other products are the factors which are pulling down the market

To identify the key trends in the industry, click on the link below:

Segments covered in the report:

For the purpose of the study, this Reports and Data has segmented the Global MicroRNA (miRNA) Market on the basis of product type, research tools and services type, application, end user and the regional outlook:

Global MicroRNA (miRNA) Key Market Segments:                      

Product Type: (Revenue, USD Million; 2016–2026)

  • Instruments
  • Kits, Reagents & Consumables
  • Isolation & Purification
  • Quantification & Detection
  • Functional Analysis
  • Others

Research Tools and Services: (Revenue, USD Million; 2016–2026)


  • qRT-PCR
  • Biomarkers
  • Next Gen Sequencing (NGS)
  • Microarray Analysis Tools
  • Functional Analysis Tools
  • Extraction Tools
  • Others


  • miRNA cDNA Synthesis
  • Quantification Services
  • Microarray Services
  • Sequencing Services
  • Functional Studies Services
  • Others

Application: (Revenue, USD Million; 2016–2026)

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

End Use: (Revenue, USD Million; 2016–2026)

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CRO
  • Diagnostic Centres

Order Now:

Regional Outlook (Revenue, USD Million; 2016-2026)

  • North America
    • U.S.
  • Europe
    • UK
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • MEA
  • Latin America
    • Brazil

Browse more reports of Pharmaceutical category at:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson

Head of Business Development

Reports And Data | Web:

Direct Line: +1-800-819-3052


RND logo.PNG